Pharmaceutics: Basic Principles & Application to
Pharmacy Practice — Test Bank (2013)
SECTION 1: FOUNDATIONS OF PHARMACEUTICS AND
PHARMACEUTICAL DOSAGE FORMS
1. Which statement best describes the central purpose of pharmaceutics in
professional pharmacy practice?
A. To identify diseases through clinical examination and laboratory investigations
B. To convert active substances into suitable medicines for safe and effective
administration
C. To determine the molecular structure of every newly discovered therapeutic
compound
D. To establish the therapeutic indication of medicines through population-based
studies
Answer: B
Rationale: Pharmaceutics applies pharmaceutical, physical, and chemical principles to
transform active drug substances into usable dosage forms. It considers formulation,
stability, administration, product quality, and drug release so that medicines can be
delivered safely and effectively.
2. A drug substance is effective when administered intravenously but produces
unreliable therapeutic effects when given orally. Which pharmaceutical consideration
is most directly relevant when investigating this difference?
A. The colour and external appearance of the manufactured product
B. The commercial packaging selected for the finished medicine
C. The number of tablets supplied in the dispensing container
D. The drug’s dissolution, absorption, and presystemic availability
Answer: D
Rationale: Oral administration requires the drug to disintegrate when applicable,
dissolve in gastrointestinal fluids, cross biological membranes, and avoid excessive
presystemic loss. Intravenous administration bypasses gastrointestinal dissolution and
absorption barriers, producing complete systemic availability of the administered dose.
3. Which term describes the physical form in which a medicine is prepared to enable
accurate administration of a drug?
A. Pharmaceutical dosage form
B. Therapeutic classification
C. Pharmacological mechanism
D. Chemical identification standard
Answer: A
,Rationale: A dosage form is the prepared physical presentation of a medicine, such as
a tablet, capsule, solution, suspension, cream, or injection. Its design supports
accurate dosing, stability, patient acceptability, and appropriate delivery of the active
pharmaceutical ingredient.
4. A pharmacist selects an oral liquid rather than a conventional tablet for a patient
who cannot swallow solid medicines. Which principle is being applied?
A. Increasing the intrinsic potency of the active ingredient
B. Eliminating all possible adverse drug reactions
C. Selecting a dosage form appropriate to the patient’s needs
D. Changing the molecular identity of the prescribed medicine
Answer: C
Rationale: Dosage-form selection should account for swallowing ability, age, clinical
condition, dose requirements, and patient preference. An oral liquid may improve
administration in patients with dysphagia, although its concentration, stability,
measuring device, and storage instructions must also be considered.
5. Which component of a pharmaceutical formulation is primarily responsible for
producing the intended pharmacological effect?
A. Preservative
B. Active pharmaceutical ingredient
C. Tablet disintegrant
D. Flavouring agent
Answer: B
Rationale: The active pharmaceutical ingredient, or API, is the substance responsible
for the intended therapeutic or pharmacological action. Excipients support
manufacturing, stability, acceptability, and delivery but are not ordinarily the
principal therapeutic component.
6. A formulation scientist finds that a drug is chemically stable but has very poor
aqueous solubility. Which development strategy is most directly intended to address
this problem?
A. Increasing the package label size
B. Changing the tablet colour and shape
C. Increasing the number of manufacturing operators
D. Selecting a suitable solubilization or formulation approach
Answer: D
Rationale: Poor aqueous solubility can limit dissolution and absorption, particularly
for oral medicines. Strategies may include salt formation, pH adjustment, cosolvents,
surfactants, complexation, particle-size reduction, or lipid-based systems, depending
on the drug’s properties and safety requirements.
,7. Why is the selection of a suitable dosage form considered a major part of
pharmaceutical product development?
A. It influences drug stability, release, administration, and patient acceptability
B. It determines the diagnosis that must be assigned to the patient
C. It ensures that every medicine produces an identical clinical response
D. It removes the need for pharmaceutical quality-control procedures
Answer: A
Rationale: Dosage-form design affects how a medicine is manufactured, stored,
administered, and released. It can influence dissolution, absorption, dose accuracy,
stability, and adherence, but it cannot guarantee identical responses because patients
and disease states differ.
8. Which description most accurately distinguishes a drug substance from a finished
pharmaceutical product?
A. A drug substance always contains preservatives, while a finished product never
does
B. A finished product contains only the active ingredient in its original chemical form
C. A finished product combines the drug substance with appropriate formulation
components
D. A drug substance must always be administered without further preparation
Answer: C
Rationale: A drug substance is the active chemical or biological material before
incorporation into its final dosage form. A finished pharmaceutical product contains
the API together with suitable excipients and is manufactured, packaged, and labelled
for administration.
9. During formulation development, a scientist evaluates whether an API reacts with a
proposed tablet binder. Which aspect of pharmaceutical development is being
investigated?
A. Therapeutic classification
B. Pharmaceutical compatibility
C. Patient counselling preference
D. Prescription authorization
Answer: B
Rationale: Compatibility studies determine whether an API interacts adversely with
excipients or packaging materials. Such interactions may cause degradation, altered
dissolution, physical instability, or reduced product performance, making
compatibility assessment essential before selecting a formulation.
10. Which outcome best demonstrates successful pharmaceutical formulation of an
active drug substance?
, A. The product has an attractive appearance regardless of its performance
B. The product contains the greatest possible quantity of excipients
C. The product can be manufactured without any quality testing
D. The product consistently meets quality standards and delivers the intended dose
Answer: D
Rationale: A successful formulation must consistently meet specifications for identity,
strength, purity, quality, and performance. Appearance and manufacturability matter,
but they cannot replace evidence that the product delivers the intended dose safely
and reliably.
SECTION 2: PHARMACEUTICAL CALCULATIONS AND
CONCENTRATION EXPRESSIONS
11. A pharmacist must prepare 500 mL of a 2% w/v solution. How much drug is
required to produce the specified final concentration?
A. 2 g
B. 5 g
C. 10 g
D. 20 g
Answer: C
Rationale: A 2% w/v solution contains 2 g of solute in every 100 mL of final solution.
For 500 mL, the required quantity is \(2 \times 5 = 10\) g, assuming the final volume
is adjusted to 500 mL.
12. A preparation contains 250 mg of an active ingredient in 5 mL of liquid. What is
its concentration in mg/mL?
A. 25 mg/mL
B. 50 mg/mL
C. 75 mg/mL
D. 100 mg/mL
Answer: B
Rationale: Concentration in mg/mL is calculated by dividing the total drug mass by
the final volume. Therefore, 250 mg divided by 5 mL gives 50 mg/mL, which can
subsequently be used to calculate an accurately measured dose volume.
13. A prescription requires 750 mg of a medicine supplied as 250 mg tablets. How
many tablets should be administered?
A. One tablet
B. Two tablets
C. Four tablets
D. Three tablets
Pharmacy Practice — Test Bank (2013)
SECTION 1: FOUNDATIONS OF PHARMACEUTICS AND
PHARMACEUTICAL DOSAGE FORMS
1. Which statement best describes the central purpose of pharmaceutics in
professional pharmacy practice?
A. To identify diseases through clinical examination and laboratory investigations
B. To convert active substances into suitable medicines for safe and effective
administration
C. To determine the molecular structure of every newly discovered therapeutic
compound
D. To establish the therapeutic indication of medicines through population-based
studies
Answer: B
Rationale: Pharmaceutics applies pharmaceutical, physical, and chemical principles to
transform active drug substances into usable dosage forms. It considers formulation,
stability, administration, product quality, and drug release so that medicines can be
delivered safely and effectively.
2. A drug substance is effective when administered intravenously but produces
unreliable therapeutic effects when given orally. Which pharmaceutical consideration
is most directly relevant when investigating this difference?
A. The colour and external appearance of the manufactured product
B. The commercial packaging selected for the finished medicine
C. The number of tablets supplied in the dispensing container
D. The drug’s dissolution, absorption, and presystemic availability
Answer: D
Rationale: Oral administration requires the drug to disintegrate when applicable,
dissolve in gastrointestinal fluids, cross biological membranes, and avoid excessive
presystemic loss. Intravenous administration bypasses gastrointestinal dissolution and
absorption barriers, producing complete systemic availability of the administered dose.
3. Which term describes the physical form in which a medicine is prepared to enable
accurate administration of a drug?
A. Pharmaceutical dosage form
B. Therapeutic classification
C. Pharmacological mechanism
D. Chemical identification standard
Answer: A
,Rationale: A dosage form is the prepared physical presentation of a medicine, such as
a tablet, capsule, solution, suspension, cream, or injection. Its design supports
accurate dosing, stability, patient acceptability, and appropriate delivery of the active
pharmaceutical ingredient.
4. A pharmacist selects an oral liquid rather than a conventional tablet for a patient
who cannot swallow solid medicines. Which principle is being applied?
A. Increasing the intrinsic potency of the active ingredient
B. Eliminating all possible adverse drug reactions
C. Selecting a dosage form appropriate to the patient’s needs
D. Changing the molecular identity of the prescribed medicine
Answer: C
Rationale: Dosage-form selection should account for swallowing ability, age, clinical
condition, dose requirements, and patient preference. An oral liquid may improve
administration in patients with dysphagia, although its concentration, stability,
measuring device, and storage instructions must also be considered.
5. Which component of a pharmaceutical formulation is primarily responsible for
producing the intended pharmacological effect?
A. Preservative
B. Active pharmaceutical ingredient
C. Tablet disintegrant
D. Flavouring agent
Answer: B
Rationale: The active pharmaceutical ingredient, or API, is the substance responsible
for the intended therapeutic or pharmacological action. Excipients support
manufacturing, stability, acceptability, and delivery but are not ordinarily the
principal therapeutic component.
6. A formulation scientist finds that a drug is chemically stable but has very poor
aqueous solubility. Which development strategy is most directly intended to address
this problem?
A. Increasing the package label size
B. Changing the tablet colour and shape
C. Increasing the number of manufacturing operators
D. Selecting a suitable solubilization or formulation approach
Answer: D
Rationale: Poor aqueous solubility can limit dissolution and absorption, particularly
for oral medicines. Strategies may include salt formation, pH adjustment, cosolvents,
surfactants, complexation, particle-size reduction, or lipid-based systems, depending
on the drug’s properties and safety requirements.
,7. Why is the selection of a suitable dosage form considered a major part of
pharmaceutical product development?
A. It influences drug stability, release, administration, and patient acceptability
B. It determines the diagnosis that must be assigned to the patient
C. It ensures that every medicine produces an identical clinical response
D. It removes the need for pharmaceutical quality-control procedures
Answer: A
Rationale: Dosage-form design affects how a medicine is manufactured, stored,
administered, and released. It can influence dissolution, absorption, dose accuracy,
stability, and adherence, but it cannot guarantee identical responses because patients
and disease states differ.
8. Which description most accurately distinguishes a drug substance from a finished
pharmaceutical product?
A. A drug substance always contains preservatives, while a finished product never
does
B. A finished product contains only the active ingredient in its original chemical form
C. A finished product combines the drug substance with appropriate formulation
components
D. A drug substance must always be administered without further preparation
Answer: C
Rationale: A drug substance is the active chemical or biological material before
incorporation into its final dosage form. A finished pharmaceutical product contains
the API together with suitable excipients and is manufactured, packaged, and labelled
for administration.
9. During formulation development, a scientist evaluates whether an API reacts with a
proposed tablet binder. Which aspect of pharmaceutical development is being
investigated?
A. Therapeutic classification
B. Pharmaceutical compatibility
C. Patient counselling preference
D. Prescription authorization
Answer: B
Rationale: Compatibility studies determine whether an API interacts adversely with
excipients or packaging materials. Such interactions may cause degradation, altered
dissolution, physical instability, or reduced product performance, making
compatibility assessment essential before selecting a formulation.
10. Which outcome best demonstrates successful pharmaceutical formulation of an
active drug substance?
, A. The product has an attractive appearance regardless of its performance
B. The product contains the greatest possible quantity of excipients
C. The product can be manufactured without any quality testing
D. The product consistently meets quality standards and delivers the intended dose
Answer: D
Rationale: A successful formulation must consistently meet specifications for identity,
strength, purity, quality, and performance. Appearance and manufacturability matter,
but they cannot replace evidence that the product delivers the intended dose safely
and reliably.
SECTION 2: PHARMACEUTICAL CALCULATIONS AND
CONCENTRATION EXPRESSIONS
11. A pharmacist must prepare 500 mL of a 2% w/v solution. How much drug is
required to produce the specified final concentration?
A. 2 g
B. 5 g
C. 10 g
D. 20 g
Answer: C
Rationale: A 2% w/v solution contains 2 g of solute in every 100 mL of final solution.
For 500 mL, the required quantity is \(2 \times 5 = 10\) g, assuming the final volume
is adjusted to 500 mL.
12. A preparation contains 250 mg of an active ingredient in 5 mL of liquid. What is
its concentration in mg/mL?
A. 25 mg/mL
B. 50 mg/mL
C. 75 mg/mL
D. 100 mg/mL
Answer: B
Rationale: Concentration in mg/mL is calculated by dividing the total drug mass by
the final volume. Therefore, 250 mg divided by 5 mL gives 50 mg/mL, which can
subsequently be used to calculate an accurately measured dose volume.
13. A prescription requires 750 mg of a medicine supplied as 250 mg tablets. How
many tablets should be administered?
A. One tablet
B. Two tablets
C. Four tablets
D. Three tablets